118 related articles for article (PubMed ID: 16613133)
1. Laboratory diagnosis of bloodstream infections caused by extended-spectrum beta-lactamase-producing E. coli and Klebsiella species.
Skippen I; Shemko M; Palmer C; Shetty N
Br J Biomed Sci; 2006; 63(1):1-4. PubMed ID: 16613133
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
3. Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamases.
Gibb AP; Crichton M
Diagn Microbiol Infect Dis; 2000 Dec; 38(4):255-7. PubMed ID: 11146252
[TBL] [Abstract][Full Text] [Related]
4. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the current National Committee for Clinical Laboratory Standards guidelines for screening and confirming extended-spectrum beta-lactamase production in isolates of Escherichia coli and Klebsiella species from bacteremic patients.
Katz OT; Peled N; Yagupsky P
Eur J Clin Microbiol Infect Dis; 2004 Nov; 23(11):813-7. PubMed ID: 15480883
[TBL] [Abstract][Full Text] [Related]
6. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
[TBL] [Abstract][Full Text] [Related]
7. Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students.
Chirindze LM; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Sundsfjord A; Essack SY; Simonsen GS
BMC Infect Dis; 2018 May; 18(1):244. PubMed ID: 29843632
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in Escherichia coli with CTX-M phenotypes.
Donaldson H; McCalmont M; Livermore DM; Rooney PJ; Ong G; McHenry E; Campbell R; McMullan R
J Antimicrob Chemother; 2008 Nov; 62(5):1015-7. PubMed ID: 18669518
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
10. Detection of extended spectrum beta-lactamase production in clinical isolates of Klebsiella spp.
Jain A; Mondal R
Indian J Med Res; 2008 Apr; 127(4):344-6. PubMed ID: 18577788
[TBL] [Abstract][Full Text] [Related]
11. Augmentation in zone of inhibition of cefoperazone/cefoperazone+ sulbactum compares well with the clinical laboratory standard institute standard extended spectrum beta-lactamase detection method as well as the polymerase chain reaction method.
Chitnis S; Katara G; Hemvani N; Chitnis DS
Curr Drug Saf; 2011 Jul; 6(3):155-8. PubMed ID: 22122390
[TBL] [Abstract][Full Text] [Related]
12. Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates.
Hadziyannis E; Tuohy M; Thomas L; Procop GW; Washington JA; Hall GS
Diagn Microbiol Infect Dis; 2000 Feb; 36(2):113-7. PubMed ID: 10705053
[TBL] [Abstract][Full Text] [Related]
13. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
Jang W; Park YJ; Park KG; Yu J
J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
[TBL] [Abstract][Full Text] [Related]
15. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
[TBL] [Abstract][Full Text] [Related]
16. Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species.
Kohner PC; Robberts FJ; Cockerill FR; Patel R
J Clin Microbiol; 2009 Aug; 47(8):2419-25. PubMed ID: 19494061
[TBL] [Abstract][Full Text] [Related]
17. Detection of extended-spectrum beta-lactamases in klebsiellae with the Oxoid combination disk method.
Carter MW; Oakton KJ; Warner M; Livermore DM
J Clin Microbiol; 2000 Nov; 38(11):4228-32. PubMed ID: 11060096
[TBL] [Abstract][Full Text] [Related]
18. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH
J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
[TBL] [Abstract][Full Text] [Related]
19. Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains.
Dashti AA; West P; Paton R; Amyes SGB
J Med Microbiol; 2006 Apr; 55(Pt 4):417-421. PubMed ID: 16533989
[TBL] [Abstract][Full Text] [Related]
20. Protocol for the accelerated detection of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains from blood cultures.
Navon-Venezia S; Ben-Ami R; Schwaber MJ; Leavitt A; Schwartz D; Carmeli Y
Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):200-2. PubMed ID: 14767680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
